James D Marks Selected Research

James D Marks Research Topics

Disease

43	Neoplasms (Cancer) 10/2020 - 04/2002
21	Botulism 01/2023 - 12/2007
8	Breast Neoplasms (Breast Cancer) 01/2018 - 09/2004
6	Prostatic Neoplasms (Prostate Cancer) 10/2014 - 01/2004
5	Respiratory Insufficiency (Respiratory Failure) 01/2021 - 01/2009
4	Chronic Obstructive Pulmonary Disease (COPD) 08/2015 - 07/2011
3	Adenocarcinoma 10/2014 - 11/2008
2	Urinary Bladder Neoplasms (Bladder Cancer) 10/2020 - 10/2014
2	Leukemia 11/2015 - 07/2010
2	Paralysis (Palsy) 08/2015 - 01/2015
2	Acquired Immunodeficiency Syndrome (AIDS) 08/2015 - 07/2010
2	Neoplasm Metastasis (Metastasis) 08/2010 - 07/2007
2	Infections 01/2009 - 12/2006
2	Carcinoma (Carcinomatosis) 01/2005 - 06/2003
1	Autoimmune Diseases (Autoimmune Disease) 10/2019
1	Carcinogenesis 11/2014
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2014
1	Melanoma (Melanoma, Malignant) 10/2014
1	Colorectal Neoplasms (Colorectal Cancer) 10/2014
1	Airway Remodeling 06/2014
1	Osteosarcoma (Osteogenic Sarcoma) 01/2012
1	Inflammation (Inflammations) 07/2011
1	Fibrosis (Cirrhosis) 07/2011
1	HIV Infections (HIV Infection) 07/2010
1	Myeloid Leukemia (Leukemia, Myelocytic) 07/2010
1	Lymphoma (Lymphomas) 07/2010
1	Immune System Diseases (Immune Disorders) 01/2009
1	Endometrial Neoplasms (Endometrial Cancer) 11/2008

Drug/Important Bio-Agent (IBA)

20	AntibodiesIBA 10/2019 - 08/2002
16	Botulinum Toxins (Botulinum Toxin)IBA 01/2023 - 02/2008
14	AntigensIBA 01/2018 - 10/2002
12	Monoclonal AntibodiesIBA 01/2021 - 04/2002
10	AntitoxinsIBA 01/2023 - 08/2010
10	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2004
8	Single-Chain AntibodiesIBA 01/2012 - 01/2004
8	Liposomes (Liposome)IBA 10/2006 - 04/2002
6	Immunoglobulin FragmentsIBA 11/2014 - 02/2005
5	incobotulinumtoxinA FDA Link 01/2023 - 12/2007
5	ErbB Receptors (EGF Receptor)IBA 01/2014 - 06/2003
4	EpitopesIBA 08/2015 - 01/2004
4	Cell Surface ReceptorsIBA 10/2012 - 01/2010
4	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2012 - 08/2002
3	AerosolsIBA 01/2021 - 01/2019
3	IntegrinsIBA 10/2018 - 07/2011
3	LigandsIBA 08/2015 - 08/2004
3	Activated-Leukocyte Cell Adhesion Molecule (Neurolin)IBA 10/2014 - 01/2012
3	Trastuzumab (Herceptin)FDA Link 01/2014 - 03/2011
3	Surface Antigens (Surface Antigen)IBA 01/2012 - 01/2004
2	ChemokinesIBA 10/2018 - 07/2011
2	Peptide Hydrolases (Proteases)FDA Link 08/2015 - 02/2010
2	Immunoglobulins (Immunoglobulin)IBA 10/2014 - 10/2007
2	DisulfidesIBA 06/2013 - 03/2006
2	Cytotoxins (Cytolysins)IBA 01/2012 - 07/2007
2	Peptides (Polypeptides)IBA 01/2012 - 03/2006
2	Radioisotopes (Radionuclides)IBA 03/2011 - 02/2008
2	Neoplasm Antigens (Tumor Antigens)IBA 11/2010 - 05/2009
2	Biomarkers (Surrogate Marker)IBA 02/2010 - 11/2008
2	Topotecan (Hycamtin)FDA LinkGeneric 01/2010 - 10/2007
2	Hormones (Hormone)IBA 05/2009 - 10/2007
1	Botulinum AntitoxinIBA 01/2023
1	Gemcitabine FDA Link 10/2020
1	ProdrugsIBA 10/2020
1	Docetaxel (Taxotere)FDA Link 10/2020
1	Type II Tumor Necrosis Factor ReceptorsIBA 10/2019
1	Phenobarbital (Luminal)FDA Link 01/2018
1	SmokeIBA 08/2015
1	ZincIBA 01/2015
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2015
1	SNARE Proteins (SNAREs)IBA 01/2015
1	Acetylcholine (Acetylcholine Chloride)FDA Link 01/2015
1	EndopeptidasesIBA 01/2015
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 11/2014
1	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 10/2014
1	Cell Adhesion MoleculesIBA 10/2014
1	Transforming Growth Factors (Transforming Growth Factor)IBA 06/2014
1	Phosphotransferases (Kinase)IBA 01/2014
1	tyrosine receptor (receptor, tyrosine)IBA 01/2014
1	NeurotoxinsIBA 06/2013
1	Recombinant ProteinsIBA 10/2012
1	Cysteine (L-Cysteine)FDA Link 06/2012
1	Immunoconjugates (Immunoconjugate)IBA 01/2012
1	Immunotoxins (Immunotoxin)IBA 01/2012
1	Membrane Glycoproteins (Membrane Glycoprotein)IBA 08/2010
1	IronIBA 07/2010
1	Transferrin Receptors (Transferrin Receptor)IBA 07/2010
1	EnzymesIBA 02/2010
1	Serine (L-Serine)FDA Link 02/2010
1	matriptaseIBA 02/2010
1	FurinIBA 12/2009
1	Vincristine (Oncovin)FDA LinkGeneric 09/2009
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 05/2009
1	Caspase 3 (Caspase-3)IBA 11/2008
1	Indicators and Reagents (Reagents)IBA 11/2008

Therapy/Procedure

14	Therapeutics 07/2012 - 08/2002
5	Critical Care (Surgical Intensive Care) 01/2021 - 01/2009
2	Immunotherapy 10/2019 - 07/2010
1	Drug Therapy (Chemotherapy) 01/2019
1	Patient Transfer (Patient Dumping) 08/2015
1	Anesthesia 08/2015
1	Intravenous Injections 03/2011